サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542535

間葉系幹細胞の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Mesenchymal Stem Cells Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 234 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
間葉系幹細胞の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 234 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

間葉系幹細胞市場の世界需要は、2023年の31億8,000万米ドルから2032年には99億3,000万米ドル近くの市場規模に達すると推定され、調査期間2024年～2032年のCAGRは13.5%です。

間葉系幹細胞、略してMSCは、骨髄、脂肪組織、臍帯血など様々な身体組織に存在する汎用性の高い成体幹細胞の一種です。骨細胞、軟骨細胞、脂肪細胞、筋肉細胞など、さまざまなタイプの細胞に変化する驚くべき能力を持つMSCは、再生医療や組織工学の分野で計り知れない可能性を秘めています。MSCはまた、その分化能力だけでなく、免疫調節特性を示し、免疫反応を調節し、組織の修復・再生プロセスを促進する上で極めて重要な役割を果たしています。このユニークな特性の組み合わせにより、MSCは整形外科的損傷、心血管系疾患、自己免疫疾患など、幅広い病態を治療する有望な候補として位置づけられています。

市場力学

間葉系幹細胞（MSCs）市場は、再生医療と細胞治療の展望を形成するいくつかの要因によって推進されています。まず、組織修復、免疫調節、再生医療におけるMSCの治療可能性に対する理解の高まりが、整形外科疾患、自己免疫疾患、神経疾患を含む様々な病状に対するMSCベースの治療に対する需要を牽引しています。加えて、慢性疾患の有病率の上昇、人口の高齢化、ライフスタイルに関連した疾患は、満たされていない医療ニーズに対応し、患者の転帰を改善する可能性を秘めた革新的な治療法に対するニーズを煽っています。さらに、細胞培養技術、細胞分離法、凍結保存技術の進歩は、MSCに基づく療法のスケーラブルな生産と臨床応用を可能にし、市場の拡大と利用しやすさを促進しています。

さらに、MSCベースの製品や治療法の規制上の承認や臨床的検証は、ヘルスケアプロバイダーや患者による市場の成長や採用を支えています。さらに、バイオテクノロジー企業、学術研究機関、製薬企業間の戦略的提携、パートナーシップ、投資は、MSCベースの療法の革新、製品開発、商業化を促進し、市場の成長と競争力を促進します。さらに、臨床研究、前臨床試験、トランスレーショナル・メディシン・イニシアティブへの投資の増加は、MSCs市場の拡大と新規治療用途の開発に寄与しています。しかし、製造の拡張性、製品品質の標準化、規制遵守などの課題は、今後数年間のMSCs市場の成長を妨げる可能性があり、これらのハードルに対処し、再生医療や細胞治療におけるMSCベースの療法の可能性を最大限に引き出すための継続的な取り組みが必要です。

この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは間葉系幹細胞の世界市場における各セグメントを包括的に評価することもできます。間葉系幹細胞産業の成長と動向は、この研究に全体的なアプローチを提供します。

市場セグメンテーション

間葉系幹細胞の市場セグメンテーションでは、国別・地域別の詳細なセグメントデータを提供し、各製品・サービスのターゲットとなる層を特定し、今後のビジネスチャンスにつなげます。

製品・サービス別

  • 製品（細胞・細胞株、キット・培地・試薬、その他）
  • サービス別

ワークフロー別

  • 細胞ソーシング＆単離
  • 培養・凍結保存
  • 分化誘導
  • 特性解析

タイプ別

  • 自家
  • 同種

分離源別

  • 骨髄
  • 臍帯血
  • 末梢血
  • 卵管
  • 胎児肝臓
  • 肺
  • 脂肪組織

適応症別

  • 骨・軟骨修復
  • 心臓血管疾患
  • 炎症および免疫疾患
  • 肝臓疾患
  • がん
  • GvHD
  • その他

用途別

  • 疾患モデリング
  • 創薬・医薬品開発
  • 幹細胞バンキング
  • 組織工学
  • トキシコロジー研究
  • その他

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの間葉系幹細胞市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 間葉系幹細胞-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 間葉系幹細胞の世界市場分析：製品・サービス別

  • 製品・サービス別概要
  • 実績データと予測データ
  • 製品・サービス別分析
  • 製品（細胞・細胞株、キット・培地・試薬、その他）
  • サービス

第6章 間葉系幹細胞の世界市場分析：ワークフロー別

  • ワークフロー別概要
  • 実績データと予測データ
  • ワークフロー別分析
  • 細胞ソーシング＆単離
  • 培養と凍結保存
  • 分化
  • 特性解析

第7章 間葉系幹細胞の世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • 自家
  • 同種

第8章 間葉系幹細胞の世界市場分析：分離元別

  • 分離元別概要
  • 実績データと予測データ
  • 分離元別分析
  • 骨髄
  • 臍帯血
  • 末梢血
  • 卵管
  • 胎児肝臓
  • 肺
  • 脂肪組織

第9章 間葉系幹細胞の世界市場分析：適応症別

  • 適応症別概要
  • 実績データと予測データ
  • 適応症別分析
  • 骨・軟骨修復
  • 心血管疾患
  • 炎症および免疫疾患
  • 肝臓疾患
  • がん
  • GvHD
  • その他

第10章 間葉系幹細胞の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 疾患モデリング
  • 創薬・医薬品開発
  • 幹細胞バンキング
  • 組織工学
  • トキシコロジー研究
  • その他

第11章 間葉系幹細胞の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第12章 間葉系幹細胞企業の競合情勢

  • 間葉系幹細胞市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第13章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Cell Applications Inc.
  • Axol Biosciences Ltd.
  • Cytori Therapeutics Inc
  • STEMCELL Technologies
  • Cyagen Biosciences.
  • Celprogen Inc
  • BrainStorm Cell Limited.
  • Stemedica Cell Technologies Inc
  • Merck KGaA（MilliporeSigma）
  • Lonza
  • PromoCell GmbH
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Services (USD MN)
  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Workflow (USD MN)
  • Cell Sourcing & Isolation Market Sales by Geography (USD MN)
  • Culture & Cryopreservation Market Sales by Geography (USD MN)
  • Differentiation Market Sales by Geography (USD MN)
  • Characterization Market Sales by Geography (USD MN)
  • Analysis by Type (USD MN)
  • Autologous Market Sales by Geography (USD MN)
  • Allogeneic Market Sales by Geography (USD MN)
  • Analysis by Source Of Isolation (USD MN)
  • Bone Marrow Market Sales by Geography (USD MN)
  • Cord Blood Market Sales by Geography (USD MN)
  • Peripheral Blood Market Sales by Geography (USD MN)
  • Fallopian Tube Market Sales by Geography (USD MN)
  • Fetal Liver Market Sales by Geography (USD MN)
  • Lung Market Sales by Geography (USD MN)
  • Adipose Tissues Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Bone And Cartilage Repair Market Sales by Geography (USD MN)
  • Cardiovascular Disease Market Sales by Geography (USD MN)
  • Inflammatory And Immunological Diseases Market Sales by Geography (USD MN)
  • Liver Diseases Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • GvHD Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Disease Modelling Market Sales by Geography (USD MN)
  • Drug Development & Discovery Market Sales by Geography (USD MN)
  • Stem Cell Banking Market Sales by Geography (USD MN)
  • Tissue Engineering Market Sales by Geography (USD MN)
  • Toxicology Studies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Mesenchymal Stem Cells Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Mesenchymal Stem Cells Report
  • Market Research Process
  • Market Research Methodology
  • Global Mesenchymal Stem Cells Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Services
  • Market Attractiveness Analysis by Workflow
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Source Of Isolation
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Services (USD MN)
  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Workflow (USD MN)
  • Cell Sourcing & Isolation Market Sales by Geography (USD MN)
  • Culture & Cryopreservation Market Sales by Geography (USD MN)
  • Differentiation Market Sales by Geography (USD MN)
  • Characterization Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Autologous Market Sales by Geography (USD MN)
  • Allogeneic Market Sales by Geography (USD MN)
  • Global Market Analysis by Source Of Isolation (USD MN)
  • Bone Marrow Market Sales by Geography (USD MN)
  • Cord Blood Market Sales by Geography (USD MN)
  • Peripheral Blood Market Sales by Geography (USD MN)
  • Fallopian Tube Market Sales by Geography (USD MN)
  • Fetal Liver Market Sales by Geography (USD MN)
  • Lung Market Sales by Geography (USD MN)
  • Adipose Tissues Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Bone And Cartilage Repair Market Sales by Geography (USD MN)
  • Cardiovascular Disease Market Sales by Geography (USD MN)
  • Inflammatory And Immunological Diseases Market Sales by Geography (USD MN)
  • Liver Diseases Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • GvHD Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Disease Modelling Market Sales by Geography (USD MN)
  • Drug Development & Discovery Market Sales by Geography (USD MN)
  • Stem Cell Banking Market Sales by Geography (USD MN)
  • Tissue Engineering Market Sales by Geography (USD MN)
  • Toxicology Studies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219961

The global demand for Mesenchymal Stem Cells Market is presumed to reach the market size of nearly USD 9.93 Billion by 2032 from USD 3.18 Billion in 2023 with a CAGR of 13.5% under the study period 2024 - 2032.

Mesenchymal stem cells, or in short MSCs are a type of versatile adult stem cell present in various bodily tissues such as bone marrow, adipose tissue, and umbilical cord blood. With their remarkable ability to transform into different cell types like bone, cartilage, fat, and muscle cells, MSCs hold immense potential in the fields of regenerative medicine and tissue engineering. Beyond their differentiation capabilities, MSCs also exhibit immunomodulatory characteristics, playing a pivotal role in regulating immune responses and facilitating tissue repair and regeneration processes. This unique combination of traits has positioned them as promising candidates for treating a wide array of medical conditions, such as orthopedic injuries, cardiovascular diseases or autoimmune disorders.

MARKET DYNAMICS

The Mesenchymal Stem Cells (MSCs) market is propelled by several factors shaping the landscape of regenerative medicine and cell therapy. Firstly, the increasing understanding of MSCs' therapeutic potential in tissue repair, immunomodulation, and regenerative medicine drives the demand for MSC-based therapies for various medical conditions, including orthopedic disorders, autoimmune diseases, and neurological disorders. Additionally, the rising prevalence of chronic diseases, aging population, and lifestyle-related ailments fuel the need for innovative treatment modalities with the potential to address unmet medical needs and improve patient outcomes. Moreover, advancements in cell culture techniques, cell isolation methods, and cryopreservation technologies enable the scalable production and clinical translation of MSC-based therapies, driving market expansion and accessibility.

Furthermore, the regulatory approvals and clinical validation of MSC-based products and therapies support market growth and adoption by healthcare providers and patients. Additionally, strategic collaborations, partnerships, and investments among biotechnology companies, academic research institutions, and pharmaceutical companies drive innovation, product development, and commercialization of MSC-based therapies, fostering market growth and competitiveness. Furthermore, increasing investments in clinical research, preclinical studies, and translational medicine initiatives contribute to the expansion of the MSCs market and the development of novel therapeutic applications. However, challenges such as manufacturing scalability, standardization of product quality, and regulatory compliance may hinder the growth of the MSCs market in the next few years, necessitating continued efforts to address these hurdles and unlock the full potential of MSC-based therapies in regenerative medicine and cell therapy.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mesenchymal stem cells. The growth and trends of the mesenchymal stem cells industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the mesenchymal stem cells market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others)
  • Services

By Workflow

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

By Type

  • Autologous
  • Allogeneic

By Source Of Isolation

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

By Indication

  • Bone And Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory And Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

By Application

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Mesenchymal Stem Cells market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Mesenchymal Stem Cells market include Thermo Fisher Scientific Inc., Cell Applications Inc., Axol Biosciences Ltd., Cytori Therapeutics Inc, STEMCELL Technologies, Cyagen Biosciences., Celprogen Inc, BrainStorm Cell Limited., Stemedica Cell Technologies Inc, Merck KGaA (MilliporeSigma), Lonza, PromoCell GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MESENCHYMAL STEM CELLS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Services
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Type
    • 3.7.4 Market Attractiveness Analysis By Source Of Isolation
    • 3.7.5 Market Attractiveness Analysis By Indication
    • 3.7.6 Market Attractiveness Analysis By Application
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY PRODUCT & SERVICES

  • 5.1 Overview by Product & Services
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Services
  • 5.4 Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Historic and Forecast Sales by Regions
  • 5.5 Services Historic and Forecast Sales by Regions

6 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY WORKFLOW

  • 6.1 Overview by Workflow
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Workflow
  • 6.4 Cell Sourcing & Isolation Historic and Forecast Sales by Regions
  • 6.5 Culture & Cryopreservation Historic and Forecast Sales by Regions
  • 6.6 Differentiation Historic and Forecast Sales by Regions
  • 6.7 Characterization Historic and Forecast Sales by Regions

7 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 Autologous Historic and Forecast Sales by Regions
  • 7.5 Allogeneic Historic and Forecast Sales by Regions

8 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY SOURCE OF ISOLATION

  • 8.1 Overview by Source Of Isolation
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Source Of Isolation
  • 8.4 Bone Marrow Historic and Forecast Sales by Regions
  • 8.5 Cord Blood Historic and Forecast Sales by Regions
  • 8.6 Peripheral Blood Historic and Forecast Sales by Regions
  • 8.7 Fallopian Tube Historic and Forecast Sales by Regions
  • 8.8 Fetal Liver Historic and Forecast Sales by Regions
  • 8.9 Lung Historic and Forecast Sales by Regions
  • 8.10. Adipose Tissues Historic and Forecast Sales by Regions

9 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY INDICATION

  • 9.1 Overview by Indication
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Indication
  • 9.4 Bone And Cartilage Repair Historic and Forecast Sales by Regions
  • 9.5 Cardiovascular Disease Historic and Forecast Sales by Regions
  • 9.6 Inflammatory And Immunological Diseases Historic and Forecast Sales by Regions
  • 9.7 Liver Diseases Historic and Forecast Sales by Regions
  • 9.8 Cancer Historic and Forecast Sales by Regions
  • 9.9 GvHD Historic and Forecast Sales by Regions
  • 9.10. Others Historic and Forecast Sales by Regions

10 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY APPLICATION

  • 10.1 Overview by Application
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Application
  • 10.4 Disease Modelling Historic and Forecast Sales by Regions
  • 10.5 Drug Development & Discovery Historic and Forecast Sales by Regions
  • 10.6 Stem Cell Banking Historic and Forecast Sales by Regions
  • 10.7 Tissue Engineering Historic and Forecast Sales by Regions
  • 10.8 Toxicology Studies Historic and Forecast Sales by Regions
  • 10.9 Others Historic and Forecast Sales by Regions

11 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE MESENCHYMAL STEM CELLS COMPANIES

  • 12.1. Mesenchymal Stem Cells Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF MESENCHYMAL STEM CELLS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Cell Applications Inc.
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Axol Biosciences Ltd.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Cytori Therapeutics Inc
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. STEMCELL Technologies
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Cyagen Biosciences.
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Celprogen Inc
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. BrainStorm Cell Limited.
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Stemedica Cell Technologies Inc
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Merck KGaA (MilliporeSigma)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Lonza
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. PromoCell GmbH
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies